We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThey came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...
Read moreAccording to the TLV, “The prices of medicines that have been on the market between 5 and 15 years...
Read moreUnder ODAP, a protocol is drawn up “with criteria for starting, stopping and effect of a medicine....
Read moreAccording to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe IPCEI was signed to address the need to equip Europe with a strong, innovative and export-friend...
Read moreAn affordable and sustainable market access landscape is key to ensure patient access to life-saving...
Read moreThe draft final guidance reverses previous guidance issued in November 2021 rejecting the drug for r...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read more